CAMBRIDGE, MA – Shimmer, a global leader in wearable technology for research applications, announced that Paolo Bonato, PhD, director of the Motion Analysis Laboratory at Spaulding Rehabilitation Hospital in Boston, has signed a letter of intent to employ Shimmer’s Verisense continuous monitoring platform during his next clinical trial to study motor recovery in stroke survivors.
The signing took place earlier today in the presence of Ireland’s Minister for Communications, Climate Action and Environment, Richard Bruton T.D. at Enterprise Ireland’s annual St. Patrick’s Day Global Ireland Lunch. The event was held at the MIT Samberg Conference Center in Cambridge, MA.
Shimmer’s Verisense wearable sensor platform was designed from the ground up to reliably capture accurate and complete biometric data, while placing minimum burden on clinical trial sponsors, sites and participants.
“We are excited to be able to use Shimmer’s new Verisense platform for our stroke study,” said Dr. Bonato. “The platform’s ability to monitor multiple sensors on a participant’s body simultaneously was crucial for this study. With Verisense, we will gain access to all the raw participant data and built-in algorithms will deliver validated metrics. Verisense sensors have a six-month battery life and can even be worn in the shower or bath, which will undoubtedly improve patient compliance and data quality. Furthermore, its monitoring dashboard will give us an overview of all the sensors in the study, while also allowing us to drill down to individual devices.”
“I would like to express my deep gratitude to Enterprise Ireland for their support of Shimmer’s Verisense platform for clinical trials, which goes well beyond facilitating this signing today. Their financial support of our development effort was integral to our ability to bring this product to market so quickly,” said Geoff Gill, president of Shimmer Americas.
Dr. Bonato is also an associate professor in the Department of Physical Medicine and Rehabilitation at Harvard Medical School, and an associate faculty member at the Wyss Institute for Biologically Inspired Engineering, Harvard University.